X0306 4 2017-03-01 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001363213 Blobel Friedhelm 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 1 1 0 0 President & CEO Common Stock 2017-03-01 4 M 0 9200 1.08 A 96726 D Common Stock 2017-03-01 4 S 0 9200 10.0011 D 87526 D Common Stock 2017-03-02 4 M 0 4417 1.08 A 91943 D Common Stock 2017-03-02 4 S 0 4417 10.0063 D 87526 D Common Stock 2017-03-03 4 M 0 6783 1.08 A 94309 D Common Stock 2017-03-03 4 S 0 6783 10.0267 D 87526 D Common Stock 2017-03-03 4 M 0 6513 3.55 A 94039 D Common Stock 2017-03-03 4 S 0 6513 10.0267 D 87526 D Non-Qualified Stock Option (right to buy) 1.08 2017-03-01 4 M 0 9200 0 D 2019-03-06 Common Stock 9200 11200 D Non-Qualified Stock Option (right to buy) 1.08 2017-03-02 4 M 0 4417 0 D 2019-03-06 Common Stock 4417 6783 D Non-Qualified Stock Option (right to buy) 1.08 2017-03-03 4 M 0 6783 0 D 2019-03-06 Common Stock 6783 0 D Non-Qualified Stock Option (right to buy) 3.55 2017-03-03 4 M 0 6513 0 D 2020-03-05 Common Stock 6513 293487 D The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2016. Includes 742 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2017. Granted under the Issuer's 2005 Equity Incentive Plan. 25% of such shares vest from one year from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer. 25% of each shares vest one year from the date of grant, of March 5,2010, and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer. /s/ Friedhelm Blobel, Ph.D. 2017-03-03